Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).Dinesh Khanna,Christopher P Denton,Celia J F Lin, Jacob M van Laar,Tracy M Frech,Marina E Anderson,Murray Baron,Lorinda Chung,Gerhard Fierlbeck,Santhanam Lakshminarayanan,Yannick Allanore,Janet E Pope,Gabriela Riemekasten,Virginia Steen,Ulf Müller-Ladner,Helen Spotswood,Laura Burke,Jeffrey Siegel,Angelika Jahreis,Daniel E FurstAnnals of the rheumatic diseases（2017）引用 249|浏览32暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
